Jason Pitts
About Jason Pitts
Jason Pitts serves as Vice President at General Atlantic and has extensive experience in the biotechnology and investment sectors, having held various roles at companies such as CinCor Pharma and Bolt Biotherapeutics.
Current Role at General Atlantic
Jason Pitts serves as Vice President at General Atlantic, a position he has held since 2021. His role involves strategic investment and advisory services, focusing on growth equity in technology and healthcare sectors. Based in New York, he contributes to the firm's mission of supporting innovative companies through capital and expertise.
Previous Experience in Biotechnology and Investment
Pitts has extensive experience in the biotechnology sector. He served as a Board Member at CinCor Pharma, Inc. from 2021 to 2023 and previously held a similar position at Bolt Biotherapeutics, Inc. for six months in 2020. Additionally, he acted as a Board Observer at Third Harmonic Bio in 2022. His background includes roles at Sofinnova Investments, where he worked as Associate and later as Principal, focusing on investment opportunities in life sciences.
Educational Background in Neuroscience
Jason Pitts earned his Doctor of Philosophy (Ph.D.) in Neuroscience from The Rockefeller University, completing his studies from 2010 to 2015. Prior to this, he obtained a Bachelor of Science (B.S.) in Neuroscience from Cornell University, where he studied from 2004 to 2008. His educational background provides a strong foundation for his roles in the biotechnology and investment sectors.
Experience in Consulting and Research
Before transitioning to the investment and biotechnology sectors, Pitts worked at McKinsey & Company as an Associate from 2016 to 2018. His earlier experience includes a role as a Research Associate at Regeneron Pharmaceuticals, Inc. from 2009 to 2010. These positions contributed to his understanding of the healthcare landscape and strategic business operations.